| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $242K | +6728.7% |
| Cost of Revenue | $279K | — |
| Gross Profit | -$37K | -1142.7% |
| R&D Expense | $433K | -2.0% |
| SG&A Expense | $785K | +46.4% |
| Operating Income | -$5.2M | -266.5% |
| Interest Expense | $576K | +1.0% |
| Net Income | -$10.2M | -399.7% |
| EPS (Diluted) | -$0.11 | -37.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $44K | — |
| Inventory | $351K | — |
| Current Assets | $3.0M | — |
| Total Assets | $3.4M | +1228.1% |
| Current Liabilities | $8.9M | +20.3% |
| Long-term Debt | $98K | -32.1% |
| Total Liabilities | $9.7M | +26.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.3M | -27.5% |
| Capital Expenditures | $192K | — |
| Investing Cash Flow | -$192K | — |
| Financing Cash Flow | $3.5M | +99.0% |
| Free Cash Flow | -$2.5M | -38.0% |
| Stockholders' Equity |
| -$6.3M |
| +14.8% |